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mean updated HbA 1c , iAUC HbA1c>norm , and total area-under-the-HbA 1c -curve (tAUC HbA1c ). For each outcome, models using each of these three glycaemic measures were compared in the following three ways: hazard or odds ratio, χ 2 statistic, and Akaike information criterion.
Results
The three glycaemic measures did not differ in their prediction of neuropathy.
iAUC HbA1c>norm was modestly superior to mean updated HbA 1c for predicting nephropathy (χ 2 P = 0.017, Akaike P = 0.032). In contrast, for predicting retinopathy, both iAUC HbA1c>norm (χ 2 P = 0.0005, Akaike P = 0.0005) and tAUC HbA1c (χ 2 P = 0.004, Akaike P = 0.0004) were significantly better than mean updated HbA 1c . Varying its HbA 1c threshold incrementally between 37 and 53 mmol/mol (5.5-7.0%), inclusive, did not improve the prediction of retinopathy by iAUC HbA1c>threshold beyond that of tAUC HbA1c, consistent with the concept of a continuous relationship between glycaemia and retinopathy, with no glycaemic threshold. 
Conclusions

Methods
The DCCT has been previously described in detail [4, 5] . In brief, 1441 participants with This difference may relate to methodologic features (e.g. neuropathy was assessed only at 5 years, while retinopathy was assessed every 6 months) or limitations in the measurement of nephropathy and neuropathy outcomes, but also may reflect a comparatively greater influence of glycaemic exposure on risk of retinopathy, as compared with the other outcomes. Thirdly, we did not detect an HbA 1c level above which iAUC HbA1c surpasses tAUC HbA1c for predicting retinopathy, consistent with the concept of a continuous relationship between glycaemia and retinopathy, with no glycaemic threshold [3] .
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© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK Finally, it should be noted that, although non-glycaemic factors may also be relevant [7] , the unmeasured effect of glycaemic exposure in the years prior to the DCCT may have limited the achievable predictive capacity of all three HbA 1c -based measures obtained during the trial.
Thus, iAUC HbA1c>norm and tAUC HbA1c from the time of diagnosis ultimately warrant study for the evaluation of total cumulative glycaemic exposure as a determinant of microvascular risk in Type 1 diabetes.
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should be directed to the corresponding author for the article. Retinopathy and nephropathy were analysed by time-dependent proportional hazards models as they were assessed regularly during the DCCT. Neuropathy was analysed by logistic regression model because it was assessed only at 5 years. Patients with urine albumin excretion rate > 40 mg/24 h at baseline were excluded from nephropathy models and those with neuropathy at baseline were excluded from neuropathy models. †A larger χ 2 statistic indicates stronger evidence of an increasing trend over time in the effect of a measure of glycaemic exposure on the hazard or risk of an outcome.
‡The Akaike information criterion offers a measure of the information lost when a statistical model is used to describe reality. Thus, in this study, given a set of models using three measures of glycaemic exposure for each outcome, the preferred model is the one with the minimum Akaike information criterion value, as least information is lost. §The pairwise comparisons were conducted using bootstrap methods (2000 bootstrap samples were drawn from the original data set with replacement). The pairwise differences of the estimated χ 2 and Akaike information criterion statistics were obtained for each bootstrap sample. The bootstrap P-values were estimated by the proportion of those bootstrapped χ 2 or Akaike values at greater than or equal to the observed pairwise difference from the original data. iAUC HbA1c>norm , incremental area-under-the-HbA 1c -curve above the normal range for the DCCT-standardized HbA 1c assay; tAUC HbA1c , total area-under-the-HbA 1c -curve; N/A, not applicable. 
